-
Debunking Myths About Products for Africa
November 20, 2013 Editor 0
Zyomyx Inc., a Fremont, Calif.-based company, is set to launch an innovative point-of-care CD4 test for HIV/AIDS treatment in sub-Saharan Africa in the coming months.
CD4 tests measure immune cell levels and help to determine when patients need to start or modify antiretroviral therapy. They are a crucial diagnostic component in HIV/AIDS treatment.
Related Posts
mHealth for HIV Treatment & Prevention: A Systematic Review of the Literature.
HIV and mothers’ milk: As luck would have it
Observing discussion forums and product innovation – A way to create consumer value? Case heart-rate monitors
Platform-based Product Design and Environmental Turbulence: The Mediating Role of Strategic Flexibility
Africa: Pros and Cons of High-Tech TB Testing
Oncology: A medical matryoshka doll
The Results Are In: Product Leaders Report a Need for Speed and a Roadmap to Sustainable Innovation How to Innovate Like an Insurance Carrier
